ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NSCI Netscientific Plc

62.50
0.00 (0.00%)
07 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Netscientific Plc LSE:NSCI London Ordinary Share GB00BN4R5Q82 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 62.50 60.00 65.00 62.50 60.50 62.50 2,811 08:00:26
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 1M -3.09M -0.1312 -4.76 14.73M

NetScientific PLC Wanda Launches CareLink, New Digital Health App (7719X)

15/08/2018 7:00am

UK Regulatory


Netscientific (LSE:NSCI)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Netscientific Charts.

TIDMNSCI

RNS Number : 7719X

NetScientific PLC

15 August 2018

NetScientific plc

("NetScientific" or the "Group")

Wanda launches new digital health app Wanda CareLink(TM) with enhanced real-time capabilities on iOS and Android devices

London, UK - August 15, 2018 - NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that portfolio company Wanda, which uses machine learning to help healthcare providers to better manage the risk and care of patients, has launched its new digital health application Wanda CareLink(TM). This application allows the Wanda Patient Management solution to be used on a wide variety of internet-enabled devices including iOS and Android devices. This enhances the ability for patients and doctors alike to improve clinical and financial outcomes.

The application is available on the Apple Store and is to become available on Google Play shortly.

Commenting on the news, Francois R. Martelet, NetScientific's Chief Executive Officer and Chairman of Wanda, said: "Wanda continues to improve its capabilities to match the needs of the market and its clients, and we believe that it will result in increased traction as healthcare providers realise the value of remote patient monitoring from both a financial and clinical standpoint. We are pleased to see Wanda's progress in strengthening its core offering and look forward to further progress."

NetScientific holds a 62% stake on a fully diluted basis in Wanda. The full announcement is included below.

For more information, please contact:

 
  NetScientific                                                       Tel: +44 (0)20 3514 
   François R. Martelet, M.D., CEO                                              1800 
   Ian Postlethwaite, CFO 
  Wanda, Inc. 
   Bill Basset, CCO                                       Tel: +1 (0)206 
                                                          910 0428 
  Consilium Strategic Communications 
   Mary-Jane Elliott / Chris Welsh / Laura Thornton                   Tel: +44 (0)20 3709 
                                                                                     5700 
                                                        netscientific@consilium-comms.com 
  WHIreland (NOMAD and Broker)                                        Tel: +44 (0)20 7220 
   Chris Fielding / Jessica Cave / Chris Viggor                                      1666 
 

About NetScientific

NetScientific is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases. For more information, please visit the website at www.netscientific.net

Predictive Patient Management Platform Expands Real-Time Mobile Capabilities

August 15, 2018 (San Francisco, CA) -- Wanda is pleased to announce the release of its new digital health application Wanda CareLink(TM) . The multi-platform application greatly expands the mobility of the Wanda Patient Management solution to be used on virtually any internet-enabled device including iOS and Android smartphones and tablets. The "bring-your-own-device" approach expands the ability for patients, doctors, and clinicians to improve care plan adherence producing better clinical and financial outcomes.

The Wanda platform empowers doctors and clinicians with the ability to know when patients will have adverse events before they happen, predicting 90% of rehospitalizations and emergency department visits seven days before they occur. The embedded predictive algorithms identify high-risk patients, alerting doctors and clinicians to the root-causes triggering the adverse events. These insights help clinical teams to assess care plans and proactively manage virtual interventions, which improve patient care plan adherence and resolve the adverse event before it happens.

"Wanda is proving to be a great solution for supporting preventative patient engagement with 74% of patients staying adherent to their care plan," stated William Bassett, Chief Commercial Officer at Wanda. "As high-risk patients are identified, Wanda facilitates better decision making, empowering doctors and clinicians with the real-time insight that will keep patients from preventable emergent situations."

The Wanda application was created from twelve years of research at UCLA, in a collaborative research project including the Medical, Nursing and Engineering Schools. After eight clinical trials yielding nine patents, the machine learning clinical algorithms have shown to predict 90% of adverse events, rehospitalizations and ED visits, seven days before the event will occur. Wanda warns of the pending adverse event detailing the risk triggers for each patient prompting the need for intervention and then facilitates clinical case management.

"Providers and payers can more easily identify and eliminate issues that have made population health and risk-based contracting a challenge," said Ahsan Samiee, Chief Technology Officer at Wanda. "The embedded data science in Wanda can now be used across a range of mobile tools to expand the efficiency of real-time patient care."

About Wanda, Inc.

Wanda is dedicated to advancing the effectiveness and efficiency of medicine by using machine learning and modern software applications that empower payers and providers to better manage the risk and care of patients dramatically lowering the cost of care and improving outcomes. More information about Wanda can be found at http://www.yourwanda.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCLLFEITFISLIT

(END) Dow Jones Newswires

August 15, 2018 02:00 ET (06:00 GMT)

1 Year Netscientific Chart

1 Year Netscientific Chart

1 Month Netscientific Chart

1 Month Netscientific Chart

Your Recent History

Delayed Upgrade Clock